Edwards Lifesciences is a leader in innovative technologies aimed at improving patient outcomes in cardiovascular care. The company specializes in transcatheter heart valves, including the SAPIEN series, which are designed for patients with severe aortic stenosis and other heart valve diseases. These minimally invasive solutions allow for valve replacement without the need for open-heart surgery, significantly reducing recovery times and associated risks. Additionally, Edwards offers transcatheter mitral and tricuspid technologies, such as the PASCAL system, which focuses on repairing heart valves non-invasively, catering to patients who are at high risk for traditional surgical procedures.

In the realm of critical care, Edwards Lifesciences provides a range of advanced monitoring and vascular solutions, including catheters and shunts that have been trusted by clinicians for over 50 years. Their products are designed for effective clot management and general surgical applications, ensuring high standards of care in various medical settings. The company is also committed to clinical research, actively conducting trials to evaluate the safety and effectiveness of their devices, thereby contributing to the advancement of cardiovascular treatments and offering hope for patients facing serious heart conditions.

United States

The company works with doctors to develop medical devices related tostructural heart disease and critical care monitoring.

Edwards Life Sciences

Company Details